Cite
MLA Citation
T Innocenti et al.. “P491 Infectious risk of vedolizumab compared with other biological agents in the treatment of Inflammatory Bowel Disease.” Journal of Crohn's and colitis, vol. 15, n.d., p. S476. http://access.bl.uk/ark:/81055/vdc_100130764871.0x000014